S C Textor

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint Renovascular hypertension: is there still a role for stent revascularization?
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA
    Curr Opin Nephrol Hypertens 22:525-30. 2013
  2. doi request reprint Renal artery stenosis: medical versus interventional therapy
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Curr Cardiol Rep 15:409. 2013
  3. pmc Percutaneous revascularization for ischemic nephropathy: the past, present, and future
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Kidney Int 83:28-40. 2013
  4. pmc Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whites
    Stephen C Textor
    Mayo Clinic, Rochester, MN 55905, USA
    Am J Kidney Dis 59:229-37. 2012
  5. pmc The uncertain value of renal artery interventions: where are we now?
    Stephen C Textor
    Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA
    JACC Cardiovasc Interv 2:175-82. 2009
  6. doi request reprint Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches
    Efrain Reisin
    Section of Nephrology and Hypertension, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
    Med Clin North Am 93:733-51. 2009
  7. pmc Current approaches to renovascular hypertension
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Med Clin North Am 93:717-32, Table of Contents. 2009
  8. doi request reprint Expanding criteria for living kidney donors: what are the limits?
    Stephen Textor
    Mayo Clinic, Rochester, MN 55905, USA
    Transplant Rev (Orlando) 22:187-91. 2008
  9. ncbi request reprint Blood pressure and renal function after kidney donation from hypertensive living donors
    Stephen C Textor
    Department of Medicine, Divisions of Nephrology and Hypertension, W9A, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Transplantation 78:276-82. 2004
  10. ncbi request reprint Ischemic nephropathy: where are we now?
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    J Am Soc Nephrol 15:1974-82. 2004

Detail Information

Publications76

  1. doi request reprint Renovascular hypertension: is there still a role for stent revascularization?
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA
    Curr Opin Nephrol Hypertens 22:525-30. 2013
    ..Management of renovascular hypertension remains controversial and problematic, in part, due to failure of prospective trials to demonstrate added benefit to revascularization...
  2. doi request reprint Renal artery stenosis: medical versus interventional therapy
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Curr Cardiol Rep 15:409. 2013
    ..Experimental data now support developing adjunctive measures to support angiogenesis and anti-inflammatory renal repair mechanisms, such as those observed with cell-based therapy with mesenchymal stem/stromal cells. ..
  3. pmc Percutaneous revascularization for ischemic nephropathy: the past, present, and future
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Kidney Int 83:28-40. 2013
    ....
  4. pmc Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whites
    Stephen C Textor
    Mayo Clinic, Rochester, MN 55905, USA
    Am J Kidney Dis 59:229-37. 2012
    ....
  5. pmc The uncertain value of renal artery interventions: where are we now?
    Stephen C Textor
    Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA
    JACC Cardiovasc Interv 2:175-82. 2009
    ....
  6. doi request reprint Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches
    Efrain Reisin
    Section of Nephrology and Hypertension, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
    Med Clin North Am 93:733-51. 2009
    ..Although we strongly believe in our proposal, more multicenter long-term clinical pharmacological trials are needed to evaluate the efficacy and safety of the antihypertensive approaches in the treatment of obesity hypertension...
  7. pmc Current approaches to renovascular hypertension
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Med Clin North Am 93:717-32, Table of Contents. 2009
    ..These elements often determine the role and timing for revascularization. In this respect, atherosclerotic renal artery stenosis is analogous to progressive carotid or aortic aneurysmal disease...
  8. doi request reprint Expanding criteria for living kidney donors: what are the limits?
    Stephen Textor
    Mayo Clinic, Rochester, MN 55905, USA
    Transplant Rev (Orlando) 22:187-91. 2008
    ..Studies to closely track the impact of donor nephrectomy in the current era with changing population demographics and expectations are essential...
  9. ncbi request reprint Blood pressure and renal function after kidney donation from hypertensive living donors
    Stephen C Textor
    Department of Medicine, Divisions of Nephrology and Hypertension, W9A, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Transplantation 78:276-82. 2004
    ..This study reports outcomes of hypertensive donors 1 year after kidney donation...
  10. ncbi request reprint Ischemic nephropathy: where are we now?
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    J Am Soc Nephrol 15:1974-82. 2004
    ..Further research should be directed toward identification of critical disease, regulation of fibrogenesis, and the interaction with other atherosclerotic processes...
  11. ncbi request reprint Hypertension after renal transplantation
    S C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    J Hum Hypertens 18:835-6. 2004
  12. pmc The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis
    Stephen C Textor
    Division of Nephrology and Hypertension, Departments of Physiology and Pathology, Center for Magnetic Imaging Research and Department of Radiology, Mayo Clinic, W19, Rochester, MN 55905, USA
    J Am Soc Nephrol 19:780-8. 2008
    ..These results suggest that BOLD MR coupled with a method to suppress tubular oxygen consumption can be used to evaluate regional tissue oxygenation in the human kidney affected by vascular occlusive disease...
  13. ncbi request reprint Renovascular hypertension in 2007: where are we now?
    Stephen C Textor
    Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Curr Cardiol Rep 9:453-61. 2007
    ..The CORAL study and others seek to randomly assign subjects with high-grade renovascular lesions to optimal medical management with and without stenting...
  14. doi request reprint Atherosclerotic renal artery stenosis: overtreated but underrated?
    Stephen C Textor
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    J Am Soc Nephrol 19:656-9. 2008
    ..Most important, nephrologists await development of tools to predict reliably when renal parenchymal injury is beyond recovery and/or when revascularization can produce meaningful salvage of kidney function...
  15. ncbi request reprint Atherosclerotic renal artery stenosis: how big is the problem, and what happens if nothing is done?
    Stephen C Textor
    Mayo Clinic College of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Hypertens Suppl 23:S5-13. 2005
    ..Renal revascularization should be considered in viable individuals before the development of advanced renal insufficiency...
  16. ncbi request reprint Progressive hypertension in a patient with "incidental" renal artery stenosis
    Stephen C Textor
    Division of Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Hypertension 40:595-600. 2002
  17. ncbi request reprint Blood pressure evaluation among older living kidney donors
    Stephen C Textor
    Department of Internal Medicine, Divisions of Hypertension and Nephrology, Mayo Clinic, Rochester, Minnesota, USA
    J Am Soc Nephrol 14:2159-67. 2003
    ..Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warranted for Caucasian subjects with high clinic BP readings who are otherwise suitable potential donors...
  18. ncbi request reprint Posttransplantation hypertension related to calcineurin inhibitors
    S C Textor
    Department of Medicine, Division of Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Liver Transpl 6:521-30. 2000
    ..Attention must be paid to interactions between antihypertensive agents and calcineurin inhibitor blood levels...
  19. ncbi request reprint Renal artery stenosis: a common, treatable cause of renal failure?
    S C Textor
    Divisions of Hypertension and Nephrology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    Annu Rev Med 52:421-42. 2001
    ..The decision to recommend revascularization remains a difficult balance between the risks and expense of the procedure and the undoubted benefits that accrue if renal function is successfully stabilized...
  20. pmc Renovascular hypertension and ischemic nephropathy
    Stephen C Textor
    Mayo Clinic, Rochester, Minnesota, USA
    Am J Hypertens 23:1159-69. 2010
    ..Until additional staging tools become available, clinicians will be forced to individualize therapy carefully to optimize the potential benefits regarding both blood pressure and renal function for such patients...
  21. pmc Timing and selection for renal revascularization in an era of negative trials: what to do?
    Stephen C Textor
    Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Prog Cardiovasc Dis 52:220-8. 2009
    ....
  22. ncbi request reprint Managing renal arterial disease and hypertension
    Stephen C Textor
    Mayo Medical School, Division of Hypertension, Mayo Clinic Rochester, Minnesota 55905, USA
    Curr Opin Cardiol 18:260-7. 2003
    ..Recognizing renal artery disease and directing revascularization procedures to those with the most benefit remains a premier challenge for the clinician...
  23. ncbi request reprint Hypertension after liver transplantation: a predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations
    S J Taler
    Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Hypertens 13:231-9. 2000
    ..5%, normal 13%), usually absent early after transplantation. Our results demonstrate the ability of hemodynamic measurements to predict the symptomatic response to antihypertensive therapy in the posttransplant setting...
  24. doi request reprint The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation
    N Leung
    Division of Nephrology and Hypertension, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA
    Am J Transplant 10:558-62. 2010
    ..Improvement in the dialysis patients was all partial. Successful KTx did not insure improvement in NSF and in fact appeared to have no significant benefit over dialysis...
  25. ncbi request reprint Glomerular volume and renal histology in obese and non-obese living kidney donors
    D J Rea
    William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55904, USA
    Kidney Int 70:1636-41. 2006
    ..08). From these data, our studies detected subtle differences in donor organs obtained from obese compared to non-obese individuals. Further studies should be carried out to quantify the long-term impact of these findings...
  26. pmc Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidney
    Victor H Urbieta-Caceres
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Physiol Renal Physiol 299:F135-40. 2010
    ..These observations underscore the direct intrarenal effect of atherogenic factors on the kidneys...
  27. ncbi request reprint Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy
    Julie K Heimbach
    Mayo Clinic College of Medicine, Department of Transplant Surgery, Rochester, Minnesota, USA
    Am J Transplant 5:1057-64. 2005
    ..While early results are encouraging, we advocate careful study of obese donors and do not support their widespread use until longer follow-up is available...
  28. ncbi request reprint Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy
    S J Taler
    Division of Hypertension and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Hypertens 8:598-605. 1995
    ..Both immunosuppressive regimens led to a loss of nocturnal blood pressure fall, as compared to ESLD patients or normotensive controls.(ABSTRACT TRUNCATED AT 250 WORDS)..
  29. ncbi request reprint Renovascular hypertension and ischemic nephropathy
    Vesna D Garovic
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Circulation 112:1362-74. 2005
  30. ncbi request reprint Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation
    Mary E Fidler
    Department of Laboratory Medicine, Division of Anatomic Pathology, Mayo Foundation and Clinic, Rochester, MN, USA
    Am J Transplant 4:101-7. 2004
    ..Glomerular thrombi appear early in AMR and may appear prior to graft dysfunction...
  31. ncbi request reprint Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis
    Alejandro R Chade
    Department of Internal Medicine, Division of Hypertension, Mayo Clinic, Rochester, Minn 55905, USA
    Arterioscler Thromb Vasc Biol 23:1295-301. 2003
    ..We tested the hypothesis that coexistence of atherosclerosis and RAS interferes with renal tissue remodeling...
  32. ncbi request reprint Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN)
    H M Wadei
    Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Transplant 6:1025-32. 2006
    ..iii) Fibrosis at the time of diagnosis predicts subsequent functional decline. Further elucidation of the natural history of PVAN and its response to individual interventions will require prospective clinical trials...
  33. ncbi request reprint Revisiting the role of nephrectomy for advanced renovascular disease
    Garvan C Kane
    Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Med 114:729-35. 2003
    ..Despite the advances in antihypertensive therapy and renal revascularization, there remains a group of patients in whom renovascular disease leads to renal atrophy and treatment-resistant hypertension...
  34. pmc Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis
    Monika L Gloviczki
    Department of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Hypertension 55:961-6. 2010
    ..1+/-2.2 versus 58.1+/-1.2; P=0.006). These data indicate that, although stenosis reduced blood flow and volume, cortical and medullary oxygenation was preserved under these conditions...
  35. ncbi request reprint Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management
    Stephen C Textor
    Division of Hypertension, Mayo Clinic, Rochester, MN, USA
    Am J Kidney Dis 42:858-63. 2003
  36. ncbi request reprint Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement
    Nelson Leung
    Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic and Foundation, Rochester, MN, USA
    Am J Transplant 5:1660-70. 2005
    ..This experience supports the feasibility of sequential living donor KTx and autologous SCT for carefully selected patients with ESRD due to AL...
  37. ncbi request reprint Kidney allograft fibrosis and atrophy early after living donor transplantation
    Fernando G Cosio
    Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic and Foundation, Rochester, Minnesota, USA
    Am J Transplant 5:1130-6. 2005
    ..GIF frequently develops in the absence of risk factors. Lower GFR post-transplant identify patients at highest risk of GIF...
  38. doi request reprint Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller
    Sanjay Misra
    Department of Radiology, Mayo Clinic College of Medicine, 200 First Street Southwest, Alfred 6460, Rochester, MN 55905, USA
    J Vasc Interv Radiol 19:833-9. 2008
    ..To describe restenosis and clinical outcomes with drug-eluting stents (DESs) and compare them to those of bare metal stents (BMSs) in the treatment of symptomatic atherosclerotic renal artery stenosis (RAS) in the same patients...
  39. ncbi request reprint Resistant hypertension: comparing hemodynamic management to specialist care
    Sandra J Taler
    Department of Medicine, Division of Hypertension and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Hypertension 39:982-8. 2002
    ....
  40. doi request reprint Embolic protection devices in patients with renal artery stenosis with chronic renal insufficiency: a clinical study
    Sanjay Misra
    Department of Radiology, Mayo Clinic College of Medicine, 200 First Street Southwest, Alfred 6460, Rochester, MN 55902, USA
    J Vasc Interv Radiol 19:1639-45. 2008
    ..To present clinical outcomes with the use of embolic protection devices (EPDs) and renal artery stents in patients with chronic renal insufficiency (CRI) and renal artery stenosis (RAS)...
  41. pmc The association between age and nephrosclerosis on renal biopsy among healthy adults
    Andrew D Rule
    Mayo Clinic, Rochester, Minnesota, USA
    Ann Intern Med 152:561-7. 2010
    ..Chronic kidney disease is common with older age and is characterized on renal biopsy by global glomerulosclerosis, tubular atrophy, interstitial fibrosis, and arteriosclerosis...
  42. ncbi request reprint Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation
    Timothy S Larson
    Department of Internal Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN 559805, USA
    Transplantation 77:838-43. 2004
    ..The purpose of this study was to compare PAK transplantation to SPK transplantation in the Thymoglobulin induction era...
  43. pmc Increased hypoxia and reduced renal tubular response to furosemide detected by BOLD magnetic resonance imaging in swine renovascular hypertension
    Sabas I Gomez
    Department of Physiology and Biomedical Engineering, Rochester, MN 55905, USA
    Am J Physiol Renal Physiol 297:F981-6. 2009
    ..This approach may allow more detailed physiologic evaluation of poststenotic kidneys in renovascular hypertension than previously possible...
  44. pmc Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond
    Lilach O Lerman
    Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Prog Cardiovasc Dis 52:196-203. 2009
    ..Identification of specific pathways producing progressive renal injury may enable development of targeted interventions to block these pathways and preserve the stenotic kidney...
  45. ncbi request reprint Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR
    Lourdes S Peña de la Vega
    Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Kidney Int 66:1654-61. 2004
    ..Donor age adversely affects deceased-donor kidney transplant outcomes, but its influence on living-donor transplantation is less well characterized...
  46. doi request reprint Hypertension in the kidney transplant recipient
    Hani M Wadei
    Department of Transplantation, Mayo Clinic College of Medicine, Jacksonville, FL, USA
    Transplant Rev (Orlando) 24:105-20. 2010
    ....
  47. pmc Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors
    Andrew D Rule
    Division of Nephrology and Hypertension, Mayo Clinic, 200 First St SW, Rochester, MN 55905
    Mayo Clin Proc 86:282-90. 2011
    ..To test the hypothesis that kidney function and metabolic risk factors are associated with glomerular density on renal biopsy samples from healthy adults...
  48. ncbi request reprint New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation
    Fernando G Cosio
    Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Kidney Int 67:2415-21. 2005
    ..Post-transplant diabetes (PTDM) is a common and serious complication of kidney transplantation. The implications of developing hyperglycemia of lesser severity are not well understood...
  49. ncbi request reprint Renovascular hypertension update
    Stephen C Textor
    Division of Nephrology and Hypertension, Department of Internal Medicine, 200 First Street, Mayo Clinic, Rochester, MN, 55905 0002, USA
    Curr Hypertens Rep 8:521-7. 2006
    ..This important trial employs distal embolic protection to prevent deterioration of renal function. Understanding the optimal role for renal revascularization depends heavily upon the successful conduct of such trials...
  50. ncbi request reprint Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography
    Charanjit S Rihal
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:309-16. 2002
    ..To determine the feasibility, safety, and clinical yield of angiographic screening among hypertensive patients undergoing coronary angiography...
  51. ncbi request reprint Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive index
    Hani M Wadei
    Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    J Am Soc Nephrol 18:1607-15. 2007
    ..Further studies are needed to determine whether restoration of normal BP pattern will confer better allograft outcome...
  52. pmc Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics
    Lizette Warner
    Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA
    Invest Radiol 46:41-7. 2011
    ..Therefore, the adjunct use of diuretics that inhibit Na reabsorption selectively in PT and TAL, Az and furosemide, respectively, may help discern tubular function by using BOLD MRI to detect changes in tissue oxygenation...
  53. doi request reprint Abnormal circadian blood pressure pattern 1-year after kidney transplantation is associated with subsequent lower glomerular filtration rate in recipients without rejection
    Hani M Wadei
    Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA
    J Am Soc Hypertens 5:39-47. 2011
    ..46, P = .01; r = 0.34, P = .03). The current study indicates that abnormal circadian BP pattern at 1 year identifies a group of kidney recipients at risk for increased kidney function loss and lower GFR 3-4 years from transplantation...
  54. ncbi request reprint Pathophysiology of ischemic nephropathy
    L Lerman
    Divisions of Hypertension and Nephrology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Urol Clin North Am 28:793-803, ix. 2001
    ..Improved understanding of these mechanisms is essential in preventing irreversible interstitial fibrosis and restoring renal perfusion...
  55. ncbi request reprint Renovascular hypertension: current concepts
    Vesna Garovic
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Semin Nephrol 25:261-71. 2005
    ..Hence, management of such patients requires close attention and periodic review regarding restenosis and progression of vascular disease...
  56. ncbi request reprint Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia
    Alejandro R Chade
    Division of Nephrology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
    Hypertension 46:772-9. 2005
    ..Notably, many of these pathways may be reversible in hypercholesterolemia, and crucial targets could potentially be identified for early interventions to preserve the kidney...
  57. ncbi request reprint Restenosis following percutaneous renal artery revascularization
    Garvan C Kane
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Nephron Clin Pract 107:c63-9. 2007
    ..The aims of this study were to determine the risk factors for restenosis and to evaluate the blood pressure outcomes of patients who underwent repeat PTRA...
  58. ncbi request reprint Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia
    Alejandro R Chade
    Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Am Soc Nephrol 17:3394-403. 2006
    ..This study suggests novel renoprotective effects of ET-A blockers and supports further exploration of strategies that target the ET pathway in HC and atherosclerosis...
  59. pmc Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension
    Jingfei Cheng
    Department of Experimental Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Am J Physiol Renal Physiol 297:F1055-68. 2009
    ..Notably, an unexpected proliferative response occurs in the stenotic kidney that undergoes atrophy...
  60. pmc Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease
    Monika L Gloviczki
    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Invest Radiol 44:566-71. 2009
    ..We sought to define the differences between regions within kidneys and to optimize selection of regions of interest for study with 1.5 and 3 Tesla systems...
  61. doi request reprint Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes
    Garvan C Kane
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
    Nephrol Dial Transplant 23:1233-40. 2008
    ..The aim of this study was to assess the results of gadolinium use to facilitate PTRA in patients with chronic kidney disease...
  62. ncbi request reprint Overcoming a positive crossmatch in living-donor kidney transplantation
    James M Gloor
    Department of Medicine, Division of Nephrology, Mayo Foundation and Clinic, 200 First St SW, Rochester, MN 55905, USA
    Am J Transplant 3:1017-23. 2003
    ..Longer follow-up will be needed, but the absence of anti-donor antibody and good early outcomes are encouraging...
  63. ncbi request reprint Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus
    T S Larson
    Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Am J Transplant 6:514-22. 2006
    ..This study shows that a CNI-free regimen using sirolimus-MMF-prednisone produces similar acute rejection rates, graft survival and renal function 1-2 years after transplantation compared to tacrolimus-MMF-prednisone...
  64. pmc Endothelial progenitor cells homing and renal repair in experimental renovascular disease
    Alejandro R Chade
    Divisions of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA
    Stem Cells 28:1039-47. 2010
    ..Importantly, manipulation of homing signals may potentially allow therapeutic opportunities to increase endogenous EPC recruitment...
  65. ncbi request reprint Surgical management of renal fibromuscular dysplasia: challenges in the endovascular era
    Michele Carmo
    Division of Vascular Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Ann Vasc Surg 19:208-17. 2005
    ..No patient developed acute or chronic renal failure. Surgical reconstruction for RFMD has excellent short-term patency. Failed PTRA or complex reconstructions did not adversely affect outcome...
  66. ncbi request reprint Decline in native renal function early after bladder-drained pancreas transplantation alone
    Marek J Mazur
    Department of Internal Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN 55905, USA
    Transplantation 77:844-9. 2004
    ..This study examines trends in native renal function during the first posttransplant year in PTA recipients with a spectrum of pretransplant glomerular filtration rates (GFR)...
  67. ncbi request reprint Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention
    Charanjit S Rihal
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Circulation 105:2259-64. 2002
    ..In patients undergoing percutaneous coronary intervention (PCI) in the modern era, the incidence and prognostic implications of acute renal failure (ARF) are unknown...
  68. ncbi request reprint Hypertension
    David G Warnock
    Nephrology Research and Training Center, and Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35213, USA
    Am J Kidney Dis 44:369-75. 2004
  69. ncbi request reprint Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension
    Daniel G Hackam
    Division of Clinical Pharmacology, University of Western Ontario, London, Ontario, Canada
    Hypertension 50:998-1003. 2007
  70. ncbi request reprint Early referral for chronic kidney disease: good for those who need it, but who are they?
    Gary L Schwartz
    Mayo Clin Proc 81:1420-2. 2006
  71. ncbi request reprint Pitfalls in imaging for renal artery stenosis
    Stephen C Textor
    Ann Intern Med 141:730-1. 2004
  72. ncbi request reprint Renovascular hypertension: problems in evaluation and management
    Robert A Kloner
    Heart Institute, Good Samaritan Hospital and Section of Cardiology, University of Southern California, Los Angeles, CA, USA
    Chest 121:964-8. 2002
  73. ncbi request reprint Cardiovascular risk linked to chronic kidney disease--but who actually has chronic kidney disease?
    Andrew D Rule
    Mayo Clin Proc 80:1267-9. 2005
  74. doi request reprint Re: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy
    Hatem Amer
    J Urol 180:780. 2008
  75. ncbi request reprint The new hypertension guidelines from JNC 7: is the devil in the details?
    Stephen C Textor
    Mayo Clin Proc 78:1078-81. 2003
  76. ncbi request reprint Acute renal failure after liver transplantation: the role of dopamine and fenoldopam
    Nelson Leung
    Liver Transpl 10:993-4. 2004